Performance and Long-term Safety of FlowOx2.0™ in Patients With Multiple Sclerosis - Impact on Spasticity and Pain
Clinical trial NCT05562453 · UNKNOWN
Trial details
- NCT number
- NCT05562453
- Sponsor
- Otivio AS
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-04
- Primary completion
- 2023-07-15
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.